Brian Outland, RHIT, CCS-P, CPC-O; Mary M. Newman, MD; Margo J. William, MHA, CMPE
This article was published online first at www.annals.org on 22 September 2015.
Acknowledgment: The authors acknowledge the contributions of Kellyn Pearson and Shari Erickson.
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M15-1933.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that she has no financial relationships or interests to disclose. Darren B. Taichman, MD, PhD, Executive Deputy Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Pfizer.
Corresponding Author: Brian Outland, RHIT, CCS-P, CPC-O, American College of Physicians, 25 Massachusetts Avenue NW, Suite 700, Washington, DC 20001; e-mail, firstname.lastname@example.org.
Current Author Addresses: Mr. Outland and Ms. William: American College of Physicians, 25 Massachusetts Avenue NW, Suite 700, Washington, DC 20001.
Dr. Newman: Park Medical Associates, 10755 Falls Road, Suite 200, Lutherville, MD 21093.
Author Contributions: Conception and design: M.M. Newman, B. Outland.
Drafting of the article: B. Outland.
Critical revision for important intellectual content: M.M. Newman, M.J. William.
Final approval of the article: M.M. Newman, B. Outland, M.J. William.
Administrative, technical, or logistic support: M.J. William.
Collection and assembly of data: B. Outland.
Outland B, Newman MM, William MJ. Health Policy Basics: Implementation of the International Classification of Disease, 10th Revision. Ann Intern Med. 2015;163:554-556. doi: 10.7326/M15-1933
Download citation file:
Published: Ann Intern Med. 2015;163(7):554-556.
The International Classification of Diseases (ICD) standardizes diagnostic codes into meaningful criteria to enable the storage and retrieval of information regarding patient care. Whereas other countries have been using ICD, 10th Revision (ICD-10), for years, the United States will transition from ICD, Ninth Revision, Clinical Modification (ICD-9-CM), to ICD-10, on 1 October 2015. This transition is one of the largest and most technically challenging changes that the medical community has experienced in the past several decades. This article outlines the implications of moving to ICD-10 and recommends resources to facilitate the transition.
Learn more about subscription options.
Register Now for a free account.
Healthcare Delivery and Policy.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only